All posts tagged
GSK wants in on Adaptimmune’s Adaptable T cell Cancer Treatment
Advanced Potions: The Top 10 Biotechs Brewing at Oxford
Which EU Immuno-Oncology Company are you Cheering for?
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
The 8 Biggest Biotech Medical Fails of 2016 in Europe
Cell Therapies: Is Commercialization holding back a Breakthrough?
UPDATE: FDA Lifts Hold on Adaptimmune’s Rare Cancer Trials
TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer
Adaptimmune Revises TCR Protocol following Phase I/IIa Failure
7 Trendy European Biotechs Listed on the NASDAQ in 2016
Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round
Infographic: The Anatomy of European Biotech
Labiotech UG, All Rights Reserved -
Send this to a friend